You are here

Breaking new ground: Highlights from the translational Advances in Stem Cells for Diabetes Symposium in Doha

Over the last decade, researchers in Qatar have made tremendous contributions in the fields of diabetes and stem cells. This is a testament to the country’s commitment to improving healthcare outcomes and advancing biomedical research. With continued investment and collaboration, we can expect to see more exciting advancements in this field in the future. Diabetes Stem Cell Program at Qatar Foundation has been supported by state-of-the-art research facilities and has made significant progress in recent years.

Under the umbrella of the collaboration between Qatar Biomedical Research Institute (QBRI) and Harvard Stem Cell Institute (HSCI), the Steering Committee of QBRI-HSCI Agreement organized the first Translational Advances in Stem Cells for Diabetes Symposium, in Doha on March 8-9, 2023. The symposium aimed to be a platform for exchanging ideas, presenting research findings, and networking with expertise in the fields of stem cells and diabetes. The symposium brought together renowned scientists in the fields of diabetes and stem cells, including Prof. Camillo Ricordi, University of Miami; Prof. Matthias Hebrok, Technical University Munich; Prof. Kenji Osafune, Kyoto University; Dr. Ramona Pop, Melton Lab, Harvard Stem Cell Institute; and Prof. Miriam Cnop, Université Libre de Bruxelles; Dr. Adrian Teo, A*STAR, Singapore; Dr. Essam M. Abdelalim, QBRI, Qatar along with multiple international and local speakers.

Over the course of two days, the conference featured keynote speeches, a panel discussion, and poster sessions that covered a wide range of topics related to the application of stem cells in diabetes research and therapy. The speakers shared their latest research findings and insights on various aspects of stem cell-based therapies for diabetes, the use of stem cells to generate beta cells, and the development of organoids for studying diabetes. The conference provided an excellent platform for scientists and participants to share their ideas and collaborate on new projects. Overall, the Translational Advances in Stem Cells for Diabetes Symposium was a great success, providing valuable insights into the latest developments in stem cell research and their application diabetes therapy.

A photo shows the panel discussion “Stem cell therapy for diabetes: from basic science to clinical translation” From left to right: Adrian Teo, Kenji Osafune, Matthias Hebrok, Camillo Ricordi , and Essam M. Abdelalim